A Study of Ruxolitinib in Combination With Nilotinib in Patients With Chronic Phase CML
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Ruxolitinib
Related studies linked through entity extraction aliases.
Efficacy and Safety of Ruxolitinib in the Treatment of Anemic Myelofibrosis Patients.
- Status
- COMPLETED
- Phase
- PHASE2
An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease (REACH-1)
- Status
- COMPLETED
- Phase
- PHASE2
Ruxolitinib for Premalignant Breast Disease
- Status
- COMPLETED
- Phase
- PHASE2
Ruxolitinib Phosphate and Chemotherapy Given Before and After Reduced Intensity Donor Stem Cell Transplant in Treating Patients With Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE1
Ruxolitinib Combined With Ibrutinib in Chronic Lymphocytic Leukemia Patients
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
PTCy and Ruxolitinib GVHD Prophylaxis in Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Long-Term Side Effects of Ruxolitinib in Treating Patients With Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis
- Status
- TERMINATED
- Phase
- PHASE2
Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy
- Status
- UNKNOWN
- Phase
- PHASE2
Dose Escalation Study to Determine the Maximum Tolerated Dose of the Combination of Ruxolitinib and Bortezomib in Patients With Relapsed or Refractory Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Phase III Study Investigating the Efficacy and Safety of Ruxolitinib in Early Myelofibrosis Patients With High Molecular Risk Mutations.
- Status
- TERMINATED
- Phase
- PHASE3
Pharmacodynamic Effects and Predictive Biomarkers With Ruxolitinib in Operable Head and Neck Cancer
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
A Study to Evaluate the Efficacy and Safety of Vismodegib in Combination With Ruxolitinib for the Treatment of Intermediate- or High-Risk Myelofibrosis (MF)
- Status
- COMPLETED
- Phase
- PHASE1
Study of INCB053914 in Subjects With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
The Ruxo-BEAT Trial in Patients With High-risk Polycythemia Vera or High-risk Essential Thrombocythemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2